Abstract
Amikacin is the 4,6-linked aminoglycoside modified at position N1 of the 2-deoxystreptamine ring (ring II) by the L-haba group. In the present study, the crystal structure of a complex between oligonucleotide containing the bacterial ribosomal A site and amikacin has been solved at 2.7 angstrom resolution. Amikacin specifically binds to the A site in practically the same way as its parent compound kanamycin. In addition, the L-haba group interacts with the upper side of the A site through two direct contacts, O2*...H-N4(C1496) and N4*-H...O6(G1497). The present crystal structure shows how the introduction of the L-haba group on ring II of aminoglycoside is an effective mutation for obtaining a higher affinity to the bacterial A site. (c) 2006 Published by Elsevier SAS.
Original language | English |
---|---|
Pages (from-to) | 1027-1031 |
Number of pages | 5 |
Journal | Biochimie |
Volume | 88 |
DOIs | |
Publication status | Published - Aug 2006 |
Keywords
- aminoglycoside
- haba group
- ribosomal decoding site
- x-ray analysis
- TRANSFER-RNA
- CRYSTALLOGRAPHY
- ANTIBIOTICS
- SUBUNIT
- AMINOGLYCOSIDES
- OLIGONUCLEOTIDE
- INSIGHTS
- BINDING